Canlyniadau Chwilio - Ronald K. Scheule

  • Dangos 1 - 16 canlyniadau o 16
Mireinio'r Canlyniadau
  1. 1
    Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn Lambs

    Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn Lambs gan Atsuyasu Sato, Jeffrey A. Whitsett, Ronald K. Scheule, Machiko Ikegami

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors

    Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors gan Hongmei Zhao, Hiraoki Hemmi, Shizuo Akira, Seng H. Cheng, Ronald K. Scheule, Nelson S. Yew

    Cyhoeddwyd 2004
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Long-term Transgene Expression from Plasmid DNA Gene Therapy Vectors Is Negatively Affected by CpG Dinucleotides

    Long-term Transgene Expression from Plasmid DNA Gene Therapy Vectors Is Negatively Affected by CpG Dinucleotides gan Bradley L. Hodges, Kristin M. Taylor, Macy F. Joseph, Sarah A. Bourgeois, Ronald K. Scheule

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    TOXICITY OF CATIONIC LIPOSOME-DNA COMPLEX IN LUNG ISOGRAFTS

    TOXICITY OF CATIONIC LIPOSOME-DNA COMPLEX IN LUNG ISOGRAFTS gan Itaru Nagahiro, Bassem N. Mora, Carlos Henrique Ribeiro Boasquevisque, Ronald K. Scheule, G. Alexander Patterson

    Cyhoeddwyd 2000
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo

    CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo gan Nelson S. Yew, Hongmei Zhao, Malgorzata Przybylska, I‐Huan Wu, Jennifer D. Tousignant, Ronald K. Scheule, Seng H. Cheng

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D

    Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D gan Kevan L. Hartshorn, Richard J. Webby, Mitchell R. White, Tesfaldet Tecle, Clark Q. Pan, Susan Boucher, Rodney J. Moreland, Erika C. Crouch, Ronald K. Scheule

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro.

    Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. gan John Marshall, Shaona L. Fang, Lynda S. Ostedgaard, Catherine R. O’Riordan, Dawn T. Ferrara, Jane F. Amara, H. Hoppe, Ronald K. Scheule, Michael J. Welsh, Alan E. Smith

    Cyhoeddwyd 1994
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease

    Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease gan Nicholas P. Clayton, Carol A. Nelson, Timothy Weeden, Kristin M. Taylor, Rodney J. Moreland, Ronald K. Scheule, Lucy Phillips, Andrew J. Leger, Seng H. Cheng, Bruce M. Wentworth

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease

    Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease gan Karen M. Ashe, Eva Budman, Dinesh S. Bangari, Craig Siegel, Jennifer B. Nietupski, Bing Wang, Robert J. Desnick, Ronald K. Scheule, John P. Leonard, Seng H. Cheng, John Marshall

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease

    Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease gan John Marshall, Karen M. Ashe, Dinesh S. Bangari, KerryAnne McEachern, Wei-Lien Chuang, Joshua Pacheco, Diane Copeland, Robert J. Desnick, James A. Shayman, Ronald K. Scheule, Seng H. Cheng

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression

    Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression gan Jennifer B. Nietupski, Gregory D Hurlbut, Robin J. Ziegler, Qiuming Chu, Bradley L. Hodges, Karen M. Ashe, Mark P. Bree, Seng H. Cheng, Richard J. Gregory, John Marshall, Ronald K. Scheule

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease

    Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease gan Mario A. Cabrera-Salazar, Matthew DeRiso, Scott D. Bercury, Lingyun Li, John T. Lydon, William Weber, Nilesh Pande, Mandy Cromwell, Diane Copeland, John P. Leonard, Seng H. Cheng, Ronald K. Scheule

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy

    Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy gan Gregory D Hurlbut, Robin J. Ziegler, Jennifer B. Nietupski, Joseph W. Foley, Lisa Woodworth, Elizabeth Meyers, Scott D. Bercury, Nilesh Pande, David W. Souza, Mark P. Bree, Michael Lukason, John Marshall, Seng H. Cheng, Ronald K. Scheule

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Timing of Therapeutic Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile Batten Disease

    Timing of Therapeutic Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile Batten Disease gan Mario A. Cabrera-Salazar, Eric M. Roskelley, Jie Bu, Bradley L. Hodges, Nelson S. Yew, James C. Dodge, Lamya S. Shihabuddin, István Sohár, David E. Sleat, Ronald K. Scheule, Beverly L. Davidson, Seng H. Cheng, Peter Lobel, Marco A. Passini

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease

    Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease gan Karen M. Ashe, Dinesh S. Bangari, Lingyun Li, Mario A. Cabrera-Salazar, Scott D. Bercury, Jennifer B. Nietupski, Christopher G. F. Cooper, Johannes M. F. G. Aerts, Edward R. Lee, Diane Copeland, Seng H. Cheng, Ronald K. Scheule, John Marshall

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

    Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial gan Eric W.F.W. Alton, David K Armstrong, Deborah Ashby, Katie J Bayfield, Diana Bilton, Emily V Bloomfield, A. Christopher Boyd, June Brand, Ruaridh Buchan, Roberto Calcedo, Paula Carvelli, Mario Chan, Seng H. Cheng, David Collie, Steve Cunningham, Heather Davidson, Gwyneth Davies, Jane C. Davies, Lee A. Davies, Maria H Dewar, Ann Doherty, Jackie Donovan, Natalie S Dwyer, Hala I Elgmati, Rosanna F Featherstone, Jemyr Gavino, Sabrina Gea‐Sorlí, Duncan M. Geddes, James Sr Gibson, Deborah R. Gill, A P Greening, Uta Griesenbach, David M. Hansell, Katharine Harman, Tracy Higgins, Samantha L. Hodges, Stephen C. Hyde, Laura Hyndman, J. Alastair Innes, Joseph Jacob, Nancy E. Jones, Brian F Keogh, Maria P. Limberis, Paul Lloyd-Evans, Alan Maclean, Michelle C Manvell, Dominique McCormick, Michael McGovern, Gerry McLachlan, Cuixiang Meng, M Angeles Montero, Hazel Milligan, Laura Moyce, Gordon Murray, Andrew G. Nicholson, Tina Osadolor, Javier Parra-Leiton, David J. Porteous, Ian A. Pringle, Emma K Punch, Kamila M Pytel, Alexandra L. Quittner, Gina Rivellini, Clare Saunders, Ronald K. Scheule, Sarah Sheard, Nicholas J. Simmonds, Keith Smith, Stephen N. Smith, Najwa Soussi, Samia Soussi, Emma J Spearing, Barbara Stevenson, Stephanie Jones, Minna Turkkila, Rosa P Ureta, Michael D Waller, Marguerite Y Wasowicz, James M. Wilson, Paul Wolstenholme-Hogg

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: